Follicular lymphoma trials in Norway

2 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Primary treatment of follicular lymphoma with rituximab-lenalidomide-tafasitamab for high-risk disease and rituximab-lenalidomide with a 1:1 randomization to tafasitamab for low-risk disease: a phase II study – NLG-FL7

  Where

  Bergen, Oslo, Toensberg, Trondheim

  Age

  18 years and over

  People

  270 worldwide

  Run by

  Karolinska University Hospital

  See details and how to join2023-508196-36-00 · EU 2023-508196-36-00
• Phase 2Taking people
  Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries

  Where

  Oslo, Trondheim

  Age

  18 years and over

  People

  80 worldwide

  Run by

  Oslo University Hospital

  See details and how to joinNCT05849857